YD Bio Ltd. (YDES) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$5.92

From 52W high−69.54%

Volume92520.00

Market cap$433.56M

P/E (TTM)—

P/S (TTM)726.5x

Div yield—

Key dataOct 19, 2026

Open

$5.92

From 52W high

−69.54%

Volume

92520.00

Market cap

$433.56M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−53.5x

P/E (TTM)

—

RSI (14)

51.3

MomentumView details →

1D Return

+3.38%

YTD Return

−52.26%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−53.5x

EV/Sales

726.4x

P/S (TTM)

726.5x

P/B (TTM)

−27.0x

ProfitabilityView details →

Gross Margin

−7.06%

Net Margin

−1392.61%

EBITDA Margin

−1357.75%

ROE (TTM)

51.78%

ROA (TTM)

−281.60%

Asset Turnover

0.18x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+30.56%

EPS CAGR 3Y

+78.57%

EBITDA YoY

—

MomentumView details →

1D Return

+3.38%

YTD Return

−52.26%

1Y Return

−70.75%

RSI (14)

51.3

vs 50D SMA

+22.46%

vs 200D SMA

−0.70%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

0.02x

Quick Ratio

0.02x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−2.97M

Op. CF (TTM)

−1.18M

Latest newsMore news →

YD Bio Limited and EG BioMed Co., Ltd. launched an AI-based 10-cancer risk factor assessment.14d ago

YD Bio Limited announced its unaudited financial results for the six months ended June 30, 2026.49d ago

Similar companies

Altimmune, Inc.ALT Prothena Corporation plcPRTA DiaMedica Therapeutics Inc.DMAC Ovid Therapeutics Inc.OVID Autolus Therapeutics plcAUTL PureTech Health plcPRTC Find similar companies →

Latest newsMore news →

YD Bio Limited and EG BioMed Co., Ltd. launched an AI-based 10-cancer risk factor assessment.14d ago YD Bio Limited announced its unaudited financial results for the six months ended June 30, 2026.49d ago